Science Explorer Back to mapMap
Discussion
Researcher · Huawei Technologies (China) · China

Linzhi Lu

Linzhi Lu publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Gastric Cancer Management and Outcomes, Helicobacter pylori-related gastroenterology studies and HER2/EGFR in Cancer Research.

ORCID 0000-0001-7526-4113 OpenAlex
World rank
#2,048,288
of 7,710,434 ranked researchers
Rank in China
#315,844
of 978,568
Works
33
Citations
302
Citations per work
9.2
h-index
10
i10-index 11Top 52% in Pulmonary and Respiratory Medicine
Linzhi Lu

What does Linzhi Lu research?

Linzhi Lu's work is mostly in Medicine (64%), Engineering (5%).

Health Sciences: 21 works · 63.6% of their workMedicine: 21 works · 63.6% of their workPulmonary and Respiratory Medicine: 6 works · 18.3% of their workSurgery: 6 works · 18.3% of their workOncology: 5 works · 15.1% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 6.5% of their workGastroenterology: 2 works · 5.4% of their workEverything else: 10 works · 31.0% of their workPhysical Sciences: 2 works · 5.4% of their workEngineering: 2 works · 5.4% of their workElectrical and Electronic Engineering: 2 works · 5.4% of their workTHEIR WORKLinzhi Lu33works
Physical Sciences5%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2163.6%
  2. Everything else1031.0%
    1. Engineering25.4%
  1. 1Pulmonary and Respiratory Medicine18% of their works
  2. 2Surgery18% of their works
  3. 3Oncology15% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Gastroenterology5% of their works
  6. 6Electrical and Electronic Engineering5% of their works

Research topics

Which keywords describe Linzhi Lu's research?

The keywords of their largest research topics: Gastric Cancer, Chemotherapy, Endoscopic Resection, Molecular Characterization, Helicobacter pylori, Inflammation, Breast Cancer and HER2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Gastric Cancer232 topics
  2. Chemotherapy212 topics
  3. Endoscopic Resection131 topic
  4. Molecular Characterization131 topic
  5. Helicobacter pylori101 topic
  6. Inflammation101 topic
  7. Breast Cancer81 topic
  8. HER281 topic
  9. Monoclonal Antibodies82 topics
  10. Fc Receptors61 topic
  11. Therapeutic Antibodies61 topic
  12. Immune Checkpoint Blockade31 topic
  13. PD-1 and PD-L131 topic
  14. Aqueous Zinc-Ion Batteries21 topic
  15. Biosimilars21 topic
  16. Cancer21 topic
  17. Energy Storage21 topic
  18. Immunogenicity21 topic
  19. Long Noncoding RNAs21 topic

Where does Linzhi Lu work?

Linzhi Lu's main affiliation in the publication record is Huawei Technologies (China), China.

How many publications and citations does Linzhi Lu have?

OpenAlex counts 33 works and 302 citations for Linzhi Lu, an h-index of 10, ranking #2,048,288 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Linzhi Lu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.